3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
37
Terminated
8
Active not recruiting
7
Recruiting
6
Unknown
5
Withdrawn
2
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
12
Pancreatic Neoplasms
7
Nasopharyngeal Carcinoma
5
Cholangiocarcinoma
5
Biliary Tract Neoplasms
4
Rectal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Cirrhosis, Familial, with Pulmonary Hypertension
3
Stomach Neoplasms
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Urinary Bladder Neoplasms
1
Rare Tumour
1
Pathologic Complete Response
1
Pancreatic Cancer Resectable
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Chemotherapy
1
Muscle Neoplasms
1
Locally Advanced Low Rectal Adenocarcinoma
1
Liver Neoplasms
1
Liver Metastases of Colorectal Cancer
1
Keratosis, Actinic
1
HER2-positive Gastric Cancer
1
Gastroesophageal Junction Cancer
1
Interventions
Specimen Handling
2
Endoscopy
2
tremelimumab
1
futibatinib
1
durvalumab
1
Taxes
1
Risk Assessment
1
Ramucirumab
1
Radiofrequency Ablation
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Itraconazole
1
Folfox protocol
1
Fluorouracil
1
Breath Tests
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma Of Esophagus
×
Fluorouracil
×
Clear all
NCT07603375
2026-05-29
TNT Esophagus
Duke University
Phase 2
Not yet recruiting
60 enrolled